Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Interest Expenses (2016 - 2022)

Arcadia Biosciences filings provide 8 years of Interest Expenses readings, the most recent being $1000.0 for Q1 2022.

  • On a quarterly basis, Interest Expenses fell 88.89% to $1000.0 in Q1 2022 year-over-year; TTM through Dec 2022 was $1000.0, a 95.45% decrease, with the full-year FY2021 number at $20000.0, down 57.45% from a year prior.
  • Interest Expenses hit $1000.0 in Q1 2022 for Arcadia Biosciences, up from -$3000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $23000.0 in Q3 2020 to a low of -$3000.0 in Q4 2021.
  • Median Interest Expenses over the past 4 years was $3000.0 (2019), compared with a mean of $6818.2.
  • Biggest five-year swings in Interest Expenses: skyrocketed 666.67% in 2020 and later crashed 120.0% in 2021.
  • Arcadia Biosciences' Interest Expenses stood at $2000.0 in 2019, then soared by 650.0% to $15000.0 in 2020, then tumbled by 120.0% to -$3000.0 in 2021, then surged by 133.33% to $1000.0 in 2022.
  • The last three reported values for Interest Expenses were $1000.0 (Q1 2022), -$3000.0 (Q4 2021), and $15000.0 (Q3 2021) per Business Quant data.